US Defence Secretary Pete Hegseth’s designation of Washington-Beijing ties as “G2” carries a “deeply problematic” meaning that sidelines United States’ allies and partners in the region, a US lawmaker has stated in a letter. “This term carries deeply problematic connotations of depicting the United States and PRC [the People’s Republic of China] as coequal and primarily cooperative powers responsible for deciding global issues while sidelining US democratic allies and partners,” the letter said. Advertisement “In reality, the Chinese Communist Party (CCP) views the United States as its primary strategic adversary…
Day: December 11, 2025
‘Major breakthroughs’: Chinese biotech firms plan global expansions after domestic success
With their domestic profits narrowing and production capacity expanding, China’s firms are continuing to widen their overseas footprints in search of new, more lucrative markets. In this series, we examine China Inc.’s next phase of “going global” and the complex, challenging international environment its companies have chosen to enter. Chinese biotech companies are expected to make major international advances over the next decade, industry leaders said, but cautioned that weak patent portfolios and protectionist measures in foreign countries may hinder this progress. As the sector’s manufacturing base and supply chain…
How China racked up a $1tn trade surplus
In a year dominated by US President Donald Trump’s tariff war, a blizzard of tit-for-tat levies and stop-start trade negotiations, China’s $1tn surplus has made clear that it remains an unstoppable trade juggernaut. While the country’s trade surplus with the US is more than $100bn lower so far this year compared with last year’s total, it has increased in a host of other destinations from south-east Asia to Europe. The result is a historic global goods surplus that reached $1.08tn in November, driven by $3.41tn of exports and surpassing every…